Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Diabetes Patients Set to Benefit From Heart Disease Data Investment
People living with diabetes could be set to benefit from a major research initiative to […]
Blood Vessel Breakthrough Major Step Towards Alzheimers Treatment
A breakthrough in our understanding of Alzheimer’s disease has revealed changes to blood vessels in […]
New AI Tool Is Better at Spotting Heart Failure Than Current Tests
A new artificial intelligence (AI) tool can help diagnose acute heart failure more accurately than […]
Spending Less Time Watching TV Could Cut Coronary Heart Disease Risk
Watching too much TV is associated with an increased risk of coronary heart disease regardless […]
Tribute to His Royal Highness The Prince Philip Duke of Edinburgh at Heart of Steel
We’ve recognised the lifelong contributions of our Royal Patron, The Prince Philip HRH Duke of […]
New BHF Chief Technology Officer Appointed
British Heart Foundation are delighted to have appointed Alex Duncan as their new Chief Technology Officer (CTO). Alex, who is […]
New Clot Busting Drug Could Improve Stroke Treatment
A new clot busting drug developed by scientists at the University of Manchester is able […]
NHS Offers Home Blood Pressure Checks to Save Thousands of Lives
Hundreds of thousands of people will be able to test their blood pressure at home, […]
BHF Teams Up With The Francis Crick Institute to Bolster Cardiovascular Research
BHF have teamed up with the Francis Crick Institute to improve understanding of cardiovascular health […]
New Technique Makes Heart Transplant Possible for More Children in Need
A new technique developed by researchers BHF funded at Great Ormond Street Hospital for Children […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more